Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

Muneera Al-Hussaini, Michael P. Rettig, Julie K. Ritchey, Darja Karpova, Geoffrey L. Uy, Linda G. Eissenberg, Feng Gao, William C. Eades, Ezio Bonvini, Gurunadh R. Chichili, Paul A. Moore, Syd Johnson, Lynne Collins, John F. DiPersio

Blood (2016) 127 (1): 122–131.

https://doi.org/10.1182/blood-2014-05-575704

Published: 2016

Includes: Supplemental data

Journal Articles

IFNγR Signaling As a Therapeutic Target To Prevent GvHD While Preserving Gvl

Jaebok Choi, PhD, Matthew L Cooper, PhD, Julie Ritchey, Lynne Collins, Julie Prior, David Piwnica-Worms, MD, PhD, John F. Dipersio, MD, PhD

Blood (2013) 122 (21): 4464.

https://doi.org/10.1182/blood.V122.21.4464.4464

Published: 2013

Journal Articles

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Muneera H. AL Hussaini, MBBS, Julie Ritchey, Michael P. Rettig, PhD, Linda Eissenberg, PhD, Geoffrey L. Uy, MD, Gurunadh Chichili, PhD, Paul A Moore, PhD, Syd Johnson, PhD, Lynne Collins, Ezio Bonvini, John F. DiPersio, MD, PhD

Blood (2013) 122 (21): 360.

https://doi.org/10.1182/blood.V122.21.360.360

Published: 2013

Journal Articles

Interruption of IFNγR Signaling Results in Altered T Cell Trafficking in Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Jaebok Choi, PhD., Edward Dela Ziga, MD, MPH, Julie Ritchey, Lynne Collins, Julie Prior, Matthew Cooper, PhD, David Piwnica-Worms, MD, PhD, John F. DiPersio, MD, PhD

Blood (2012) 120 (21): 455.

https://doi.org/10.1182/blood.V120.21.455.455

Published: 2012

Journal Articles

IFNγR signaling mediates alloreactive T-cell trafficking and GVHD

Jaebok Choi, Edward D. Ziga, Julie Ritchey, Lynne Collins, Julie L. Prior, Matthew L. Cooper, David Piwnica-Worms, John F. DiPersio

Blood (2012) 120 (19): 4093–4103.

https://doi.org/10.1182/blood-2012-01-403196

Published: 2012

Includes: Supplemental data

Journal Articles

Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

Michelle A Hurchla, Antonio Garcia-Gomez, Mary C Hornick, Enrique M Ocio, Aixiao Li, Juan F Blanco, Lynne Collins, Christopher J Kirk, David Piwnica-Worms, Ravi Vij, MD, Michael H Tomasson, Atanasio Pandiella, Jesús F San Miguel, Mercedes Garayoa, Katherine N Weilbaecher

Blood (2011) 118 (21): 2906.

https://doi.org/10.1182/blood.V118.21.2906.2906

Published: 2011

Journal Articles

Interruption of the IFN γR/CXCR3 Axis Results in Altered T Cell Trafficking In Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Jaebok Choi, PhD., Edward Dela Ziga, MD, MPH, Julie Ritchey, Julie Prior, Lynne Collins, Johnny Wei, David Piwnica-Worms, MD, PhD, John F. DiPersio, MD, PhD

Blood (2011) 118 (21): 2971.

https://doi.org/10.1182/blood.V118.21.2971.2971

Published: 2011

NARROW

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

IFNγR Signaling As a Therapeutic Target To Prevent GvHD While Preserving Gvl

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Interruption of IFNγR Signaling Results in Altered T Cell Trafficking in Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

IFNγR signaling mediates alloreactive T-cell trafficking and GVHD

Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

Interruption of the IFN γR/CXCR3 Axis Results in Altered T Cell Trafficking In Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Email alerts

ASH Publications

American Society of Hematology

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

IFNγR Signaling As a Therapeutic Target To Prevent GvHD While Preserving Gvl

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Interruption of IFNγR Signaling Results in Altered T Cell Trafficking in Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

IFNγR signaling mediates alloreactive T-cell trafficking and GVHD

Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

Interruption of the IFN γR/CXCR3 Axis Results in Altered T Cell Trafficking In Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only